plasmid pMR1 (Fig. 1A) . A PCR-generated chloramphenicol acetyltransferase-encoding gene (cat) with flanking PstI restriction sites (10) was inserted into a unique PstI site, resulting in pMR2 (Fig. 1B ). An 837-bp segment of the 5Ј hemH sequence was deleted by PCR amplification of pMR2 with oligonucleotides del1BglII (GAAGATCTCAGGCGTTTAAGGGCACC) and del2BglII (GAAGATCTTTTGCCAAACTTGGATATT), containing flanking BglII restriction sites. Subsequent ligation of the BglII sites resulted in plasmid pMR3 (Fig. 1C ). The hemH:: cat gene from pMR2 and the ЈhemH(⌬837)::cat gene from pMR3 were amplified again by PCR, using oligonucleotides hemH1 and hemH2, and the DNA fragments were retransformed into H. influenzae strain Rd and H. influenzae type b strain Eagan (Hib), respectively. Chloramphenicol-resistant (Cm r ) colonies were obtained on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, Mich.) supplemented with hemin (20 g/ml) (Sigma), NAD (10 g/ml) (Sigma), and chloramphenicol (2 g/ ml) (Sigma). Transformants were designated SCH01 (Rd hemH:: cat) and SCH02 [Hib; hemH(⌬837)::cat]. Correct gene replacement in both strains was verified by PCR ( Fig. 1D) and Southern blot analysis (data not shown).
Characterization of hemH growth phenotypes. Strains SCH01 and SCH02 were tested for their abilities to grow on PPIX-or hemin-supplemented BHI medium. Both hemH mutants failed to grow on medium supplemented with PPIX (20 g/ml) (Sigma) but grew well on medium containing hemin (20 g/ml) ( Table 1) . Complementation of both strains with plasmid pMR1 resulted in growth of both strains on PPIX-containing medium ( Table 1 ), indicating that hemH was responsible for utilization of PPIX. We further tested the ability of strain SCH01 to grow on hemin as an intracellular iron source. To establish ironlimiting conditions, BHI medium was supplemented with the iron chelator deferoxamine mesylate (DFX) (Sigma), which preferentially chelates extracellular iron. We observed no growth of the wild-type (wt) Rd strain on BHI medium with PPIX (20 g/ml) supplemented with DFX (0.08 mM), indicating that under these conditions no iron source was available for hemin biosynthesis (Table 1) . With hemin instead of PPIX, both the wt Rd and the hemH mutant SCH01 could grow in the presence of DFX. This finding demonstrates that both strains can utilize hemin as an iron source and that if HemH could release iron from hemin, as has previously been suggested (11) , then an additional cytoplasmic hemin-utilizing and iron liberation system must coexist with hemH.
The in vivo relevance of hemH was assessed by intraperitoneal and intranasal inoculation of 5-day-old Sprague-Dawley infant rats (14, 15) . Infant rats were inoculated intraperitoneally with 100 l of 0.1% gelatin in phosphate-buffered saline containing 10 2 CFU of wt Hib (n ϭ 5) or the hemH mutant Hib strain SCH02 (n ϭ 5). At 48 h, there was no difference in bacteremia (2.78 ϫ 10 6 Ϯ 1.9 ϫ 10 6 CFU/ml for wt Hib [mean Ϯ standard deviation] versus 2.98 ϫ 10 6 Ϯ 2.1 ϫ 10 6 CFU/ml for SCH02), and all animals died by 72 h, suggesting that the two strains had similar virulence. Infant rats were also inoculated intranasally with 10 l of 0.1% gelatin-phosphatebuffered saline containing 10 7 CFU of wt Hib (n ϭ 3) or SCH02 (n ϭ 3). There was no difference in recovery (around 10 3 to 10 4 CFU) of either strain from 40-l nasal washings at 48 h. These experiments indicate that HemH is not essential for bloodstream survival or nasopharyngeal colonization and suggest that PPIX is not a major in vivo source of factor X. a BHI medium containing NAD (10 g/ml) was supplemented with hemin (20 g/ml) or PPIX (20 g/ml), with or without DFX (0.08 mM).
b ND, not done.
